Halozyme Therapeutics, Inc. HALO
3 trading plans running, 12 Form 144 notices for $53.4M
10-Q, 10-K and Form 144What HALO's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 22, 2024 to Jul 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Matthew Posard Director |
Adopted 10b5-1 plan | Jun 15, 2026 | 10-Q Aug 6, 2026 |
| Mahesh Krishnan Director |
Adopted 10b5-1 plan | Mar 19, 2026 | 10-Q May 11, 2026 |
| Helen Torley President and Chief Executive Officer |
Adopted 10b5-1 plan | Dec 3, 2025 | 10-K Feb 17, 2026 |
| Nicole LaBrosse Senior Vice President and Chief Financial Officer |
Ended 10b5-1 plan | Dec 2, 2025 | 10-K Feb 17, 2026 |
| Nicole LaBrosse Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Jun 11, 2025 | 10-Q Aug 5, 2025 |
| Bernadette Connaughton Director |
Adopted 10b5-1 plan | May 29, 2025 | 10-Q Aug 5, 2025 |
| Helen Torley President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 21, 2025 | 10-Q May 6, 2025 |
| Michael J. LaBarre Senior Vice President and Chief Technical Officer |
Adopted 10b5-1 plan | Sep 18, 2024 | 10-Q Oct 31, 2024 |
| Jeffrey W. Henderson Director (Board Chair) |
Adopted 10b5-1 plan | Sep 17, 2024 | 10-Q Oct 31, 2024 |
| Nicole LaBrosse Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Mar 22, 2024 | 10-Q May 7, 2024 |
| Helen Torley President and Chief Executive Officer |
Ended 10b5-1 plan | Jan 30, 2024 | 10-Q May 7, 2024 |
Show the other 3 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Sep 16, 2026 | MATTHEW POSARD Director |
34,226 | $3.6M |
| Aug 17, 2026 | Helen Torley President, CEO, Director |
240,000 | $23.7M |
| Aug 11, 2026 | CORTNEY A CAUDILL Officer |
41,702 | $4.3M |
| Aug 10, 2026 | BERNADETTE CONNAUGHTON Director |
1,626 | $168K |
| Jun 29, 2026 | MAHESH KRISHNAN Director |
7,304 | $548K |
| May 15, 2026 | NICOLE LABROSSE Former Officer |
14,700 | $987K |
| May 11, 2026 | Helen Torley President, CEO, Director |
101,923 | $6.5M |
| May 1, 2026 | BERNADETTE CONNAUGHTON Director |
4,875 | $310K |
| Mar 10, 2026 | CORTNEY A CAUDILL Officer |
8,857 | $599K |
| Mar 9, 2026 | CORTNEY A CAUDILL Officer |
20,000 | $1.4M |
| Feb 3, 2026 | Helen Torley President, CEO, Director |
150,000 | $11.2M |
| Jan 5, 2026 | BERNADETTE CONNAUGHTON Director |
2,000 | $141K |
Show the other 4 notices
From the Form 144 XML filed with the SEC, since Jan 5, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HALO/export.csv") into a cell.